-
Founded in:
1998-07-19 -
Country:
China -
Address:
No. 9, Jinhui Street, Hunnan New District, Shenyang -
Tax NO.:
912101127209312097 -
Registered Funds:
5 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| gastrodia tuber |
|
0 | ||
| RHIZOMA ET RADIX NOTOPTERYGII |
|
0 | ||
| Angelicae Pubescentis Radix |
|
0 | ||
| Eucommia ulmoides (fried with salt) |
|
0 | ||
| Achyranthis bidentatae radix |
|
0 | ||
| Fenugreek |
|
0 | ||
| Radix Aconiti Lateralis Preparata Rhizoma Cyperi extract |
|
0 | ||
| Angelicae Sinensis Radix |
|
0 | ||
| REHMANNIAE RADIX PRAEPARATA |
|
0 | ||
| Scrophulariae Radix |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Salvia Root P.E Tanshinone IIA 20% |
It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.
More
It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids. |
0 | ||
| NOTOGINSENG RADIX ET RHIZOMA |
It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.
More
It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids. |
0 | ||
| Borneol |
It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.
More
It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids. |
507-70-0 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Borneol |
Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, maintain normal permeability, and improve blood rheology
More
Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, maintain normal permeability, and improve blood rheology |
507-70-0 | 1 | |
| Riligustilide |
Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, maintain normal permeability, and improve blood rheology
More
Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, maintain normal permeability, and improve blood rheology |
89354-45-0 | 0 | |
| Salvia Root P.E Tanshinone IIA 20% |
Protect ischemic brain tissue, reduce whole blood and plasma viscosity, and improve blood rheology
More
Protect ischemic brain tissue, reduce whole blood and plasma viscosity, and improve blood rheology |
0 | ||
| Cmnamomi Mmulus |
Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, and maintain normal permeability
More
Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, and maintain normal permeability |
0 | ||
| FLOS SOPHORAE |
Reduce whole blood and plasma viscosity and improve blood rheology
More
Reduce whole blood and plasma viscosity and improve blood rheology |
0 | ||
| Astragali Radix |
Enhance the deformability of red blood cells and improve blood rheology
More
Enhance the deformability of red blood cells and improve blood rheology |
0 | ||
| Aucklandiae Radix |
Improve cardiovascular circulation
More
Improve cardiovascular circulation |
0 | ||
| NOTOGINSENG RADIX ET RHIZOMA |
Reduce platelet aggregation, reduce fibrinogen, and improve blood rheology
More
Reduce platelet aggregation, reduce fibrinogen, and improve blood rheology |
0 | ||
| Hawthorn |
Reduce whole blood and plasma viscosity and improve blood rheology
More
Reduce whole blood and plasma viscosity and improve blood rheology |
0 | ||
| CURCUMAE RADIX |
Protect ischemic brain tissue and improve blood rheology
More
Protect ischemic brain tissue and improve blood rheology |
0 | ||
| ALISMATIS RHIZOMA |
Reduce whole blood and plasma viscosity and improve blood rheology
More
Reduce whole blood and plasma viscosity and improve blood rheology |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ribavirin |
Antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.
More
Antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus. |
36791-04-5 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Anisodamine |
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasm caused by acetylcholine, can also relieve microvascular spasm, improve microcirculation, relax gastrointestinal smooth muscle and inhibit its peristalsis; its effect is slightly weaker than atropine, its effect of inhibiting gastrointestinal gland secretion is 1/10 of atropine, and its effect of inhibiting saliva secretion and dilating the pupil is weaker, which is 1/20-1/10 of atropine; because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine.
More
It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasm caused by acetylcholine, can also relieve microvascular spasm, improve microcirculation, relax gastrointestinal smooth muscle and inhibit its peristalsis; its effect is slightly weaker than atropine, its effect of inhibiting gastrointestinal gland secretion is 1/10 of atropine, and its effect of inhibiting saliva secretion and dilating the pupil is weaker, which is 1/20-1/10 of atropine; because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine. |
17659-49-3 | 6 |